Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month price target to $175

MT NewswiresJun 11 23:15

Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference

MINNEAPOLIS, June 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive

GlobeNewswireJun 4 20:00

Inspire Medical Systems Is Maintained at Neutral by B of A Securities

Inspire Medical Systems Is Maintained at Neutral by B of A Securities

Dow JonesJun 3 20:05

Inspire Medical Systems Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/03/2024 16.51% B of A Securities $225 → $185 Maintains Neutral 05/08/2024 60.59% Piper Sandler $250 → $

BenzingaJun 3 19:51

Express News | Inspire Medical Systems Inc: Bank of America Securities lowers price target from $225 to $185 global silver research.

BreakingsJun 3 19:04

Express News | Inspire Medical Systems Inc : BofA Global Research Cuts Price Objective to $185 From $225

BreakingsJun 3 19:03